| 000 | 01489 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516154454.0 | ||
| 264 | 0 | _c20140318 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/jth.12324 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKittelson, J M | |
| 245 | 0 | 0 |
_aBalancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cAug 2013 |
||
| 300 |
_a1443-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aHemorrhage _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMorpholines _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aRivaroxaban |
| 650 | 0 | 4 |
_aThiophenes _xtherapeutic use |
| 650 | 0 | 4 |
_aVenous Thromboembolism _xtherapy |
| 700 | 1 | _aSpyropoulos, A C | |
| 700 | 1 | _aHalperin, J L | |
| 700 | 1 | _aKessler, C M | |
| 700 | 1 | _aSchulman, S | |
| 700 | 1 | _aSteg, G | |
| 700 | 1 | _aTurpie, A G G | |
| 700 | 1 | _aCutler, N R | |
| 700 | 1 | _aHiatt, W R | |
| 700 | 1 | _aGoldenberg, N A | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 11 _gno. 8 _gp. 1443-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jth.12324 _zAvailable from publisher's website |
| 999 |
_c22842252 _d22842252 |
||